Nombre de usuario
Contraseña
Recordarme
V CURSO ISCI. DIABETES Y NUEVAS TECNOLOGÍAS Málaga, 30 y 31 de Marzo 2012
6 de marzo. Valencia. FORO DE ENDOCRINOLOGIA Y NUTRICION
25 de enero. ASAMBLEA GENERAL EXTRAORDINARIA
54 Congreso Nacional de Endocrinología y Nutrición. 23 al 25 de mayo
5 al 9 de mayo. 15th International Congress of Endocrinology and 14th European Congress of Endocrinology
XXIII CONGRESO NACIONAL DE LA SOCIEDAD ESPAÑOLA DE DIABETES Vigo, 19 al 21 de abril, 2012.
7 al 10 marzo- 15vo Congreso Mundial de Endocrinología Ginecológica
8 al 11 de febrero 2012 - 5th International Conference on Advanced Technologies & Treatments for Diabetes
Jornada sobre Hiponatremia. 16 de Febrero. Hospital La Fe de Valencia
24 de Marzo. Reunión de Primavera. Hospital de Manises.
8 de marzo "Nueva Herramienta para la optimización de la terapia con insulina" Hospital La Fe Valencia
Agencia Española de Medicamentos y Productos Sanitarios. Aliskireno riesgo-beneficio
I convocatoria de Ayudas de la Fundación SEEN a la investigación clínica y básica en Endocrinología y Nutrición
Documento consenso de la SEEN, SEMNIM y AEMPS sobre el uso del Thyrogen durante el período de restricción
Documento informativo de la SEEN acerca del uso de GH en el tratamiento de patologia neurologica en pacientes no deficitarios de GH
Ya está disponible en la zona privada de socios las ponencias del XXIII congreso de la SVEDYN 2011
Ya está disponible en la Zona Privada de Socios las ponencias de la X jornada de interrelación sobre diabetes y endocrinología entre Atención primaria y especializada
Resolución de la Agencia Valenciana De Salud sobre el uso racional de productos farmacéuticos
Ya está disponible en la Zona Privada de Socios las ponencias sobre Actualización en Neuropatía Diabética
Apertura del plazo de solicitud de Beca de la Svedyn para el mantenimiento de la página web de la sociedad
AEMPS Nota Informativa: problema de suministro de Apidra (insulina Glulisina)
8 de noviembre de 2011 Foro de Endocrinología y Nutrición Hospital General Universitario
OFERTA DE TRABAJO ENDOCRINOLOGÍA Y NUTRICIÓN ALICANTE
Comunicado FDA: Actualización de la revisión de seguridad de la hormona de crecimiento humana recombinante y su posible aumento de riesgo de muerte
Diabetes y Ramadán
FDA Drug Safety Communication: Ongoing safety review of oral bisphosphonates and potential increased risk of esophageal cancer
Nota informativa de la AEMPS: PIOGLITAZONA, RESULTADOS DE LA EVALUACIÓN EUROPEA SOBRE SU POSIBLE ASOCIACIÓN CON EL CÁNCER DE VEJIGA
Jornada sobre actualización en Neuropatía Diabética
Nota informativa de la AEMPS sobre Pioglitazona
Update on ongoing European review of pioglitazone containing medicines
Nota informativa de la SEEN sobre el uso de la pioglitazona
Plaza de Endocrinología y Nutrición. Hospital de Galdakao
Comunicado de la AEMPS acerca de la reutilización de las agujas para inyección de insulina
X Jornada de Interrelación sobre Diabetes y Endocrinología entre Atención Primaria y Especializada
Public Health Statement from the American Thyroid Association: Warning too Much Thyroid Hormone Increases Bone Fractures in the Elderly
RICIBA: Registro Informatizado de CIrugía Bariátricas
II Reunión Multidisciplinar de Proyectos del GNE
Foro de Endocrinología y Nutrición Hospital General Universitario
FDA approves new treatment for Type 2 diabetes
Nota informativa de la AEMPS sobre bifosfonatos y riesgo de fracturas atípicas de fémur
Jornada sobre Neuropatía Diabética
CONGRESO SVEDYN 2011
Ya están disponibles los casos clínicos de la Reunión de Primavera 2011
FDA approves new treatment for medullary thyroid cancer
RADIATION RISKS TO HEALTH
Centros de estudios genéticos en España
IDD Newsletter 2011
NOTA SVEDyN sobre el Manual: Uso Tiras Reactivas de glucosa en sangre
Estandarizacion metodos determinacion de somatotropina
ESTANDARIZACIÓN INMUNOANÁLISIS GH
Conclusiones IV Reunión de Interrelación 2009
Comunicado SEEN-SED ROSIGLITAZONA
The genetics of phaeochromocytoma
REVIEW: Pheochromocytoma and pregnancy
REVIEW THERAPY OF ENDOCRINE DISEASE Insulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analogues
JCEM Evaluation of Ovarian Reserve Based on Hormonal Parameters, Ovarian Volume, and Antral Follicle Count in Women with Type 2 Diabetes Mellitus
JCEM Bone Mineral Density Is Not Significantly Reduced in Adult Patients on Low-Dose Glucocorticoid Replacement Therapy
JCEM Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice Guideline
European Journal of Endocrinology Body composition and quality of life in adults treated with GH therapy: a systematic review and meta-analysis
Approach to the patient with advanced differentiated thyroid cancer M Schlumberger and S I Sherman European Journal of Endocrinology (2012) 166 5–11
NEJM clinical practice: Primary Hyperparathyroidism
ADA Standards of Medical Care in Diabetes 2012
Editorial. Niacin at 56 Years of Age, Time for an Early Retirement?
NEJM: Niacin in Patients with Low HDL Levels Receiving Intensive Statin Therapy
Clinical Review: Clinical Utility of Thyroglobulin Antibody (TgAb) Measurements for Patients with Differentiated Thyroid Cancers
Approach to the patient with gestational diabetes after delivery
Contributions of Basal and Postprandial Hyperglycemia Over a Wide Range of A1C Levels Before and After Treatment Intensification in Type 2 Diabetes
Effects on 11 years mortality and morbidity of lowering LDL with simvastatin for about 5 years in 20536 high-risk individuals: a randomised controlled trial
Evaluation of Nonfasting Tests to Screen for Childhood and Adolescent Dysglycemia
Effect of Stopping Risedronate after Long-Term Treatment on Bone Turnover
NEJM: Intensive Diabetes Therapy and Glomerular Filtration Rate in Type 1 Diabetes
Antithyroid Drug-Induced Hematopoietic Damage: A Retrospective Cohort Study of Agranulocytosis and Pancytopenia Involving 50,385 Patients with Graves' Disease
Clinical DIabetes: The 3 R of glycemic index: Recommendations, Research, and the Real world
Is Blood Pressure Target of less than 130/80 mmHg still appropriate for High-Risk Patients?
Abstracts of the 81st Annual Meeting of the American Thyroid association
Approach to the patient with persistent or recurrent primary hyperparathyroidism
JCEM uptodate: Endocrine dysregulation in Anorexia Nervosa.
Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum
Postprandial blood glucose predicts cardiovascular events and all-cause mortality int type 2 diabetes
Metformin therapy during pregnancy
Aiming at new targets to achieve normoglycemia during pregnancy
The use of an early postoperative CRH test to assess adrenal function after transsphenoidal surgery for pituitary adenomas
Women of childbearing age benefit of iodine supplementation before conception
Comparison of HbA1c With Fasting Plasma Glucose and 2-h Postchallenge Glucose for Risk Stratification Among Women With Recent Gestational Diabetes Mellitus
Incretin-Based Therapy and the Quest for Sustained Improvements in β-Cell Health
Effects of Simvastatin and Metformin on Polycystic Ovary Syndrome
Subclinical and Overt Hypothyroidism are Associated with Increased All-Cause Mortality.
Metformin and Chronic Renal Impairment: A Story of Choices and Ugly Ducklings.
MODY: History, genetics, pathophysiology, and clinical decision making
Deriving Ethnic-Specific BMI Cutoff Points for Assessing Diabetes Risk
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
NEJM Clinical Practice: Glucocorticoid-Induced Bone Disease
Changes over time in glycemic control and β-cell function in response to metformin and Thiazolidinedione in impaired glucose tolerance
Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy: A Meta-analysis
Etiological Approach to Characterization of Diabetes Type: The SEARCH for Diabetes in Youth Study
Endocrine Society Clinical Practice Guideline: Evaluation and Treatment of Adult Growth Hormone Deficiency
NEJM: Drugs and Pheochromocytoma — Don’t Be Fooled by Every Elevated Metanephrine
Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists
Deiodinases: keeping the thyroid hormone supply in balance
EHJ: Triglyceride and HDL in high risk of cardiovascular disease: evidence and guidance for management.
Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency
Glycemic Control, Complications, and Death in Older Diabetic Patients
Influence of Time of Day of Blood Pressure–Lowering Treatment on Cardiovascular Risk in Hypertensive Patients With Type 2 Diabetes
NEJM: Selenium and the Course of Mild Graves’ Orbitopathy
Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combination.
Association between thyroid autoantibodies and miscarriage and preterm birth
GH replacement therapy in elderly GH-deficient patients: a systematic review
Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion
Pituitary Incidentaloma: An Endocrine Society Clinical Practice Guideline
Evidence Linking Hypoglycemic Events to an Increased Risk of Acute Cardiovascular Events in Patients With Type 2 Diabetes
Vitamin D levels, Microvascular Complications, and Mortality in Type 1 Diabetes.
BMJ Clinical Practice: Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in hypertension
Pitfalls in Outpatient Diabetes Management and Inpatient Glycemic Control
A Rare Complication of Diabetic Ketoacidosis
Diabetes in the Emergency Department: Acute Care of Diabetes Patients
Current management practices for acromegaly: an international survey
Practice Recommendations of The American Thyroid Association on Radioiodine Safety.
International Diabetes Federation Position Statement: Bariatric Surgery in the Treatment of Obesity and Type 2 Diabetes.
BMJ Clinical Practice: Hypoglycaemia
Effect of Continuous Glucose Monitoring in Type 1 Diabetes
Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations
Thyroid hormones & fetal neurological development
BMJ Lesson of the week: Pituitary Infarction
Clinical Practice Guideline of Intensive Insulin Therapy in Hospitalized Patients
Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
Diabetic retinopathy
Inpatient Management of Hyperglycemia and Diabetes
Hypoglycemia
Continuous glucose monit
REVIEW Kisspeptin and fertility
XXIII congreso de la SVEDYN en Alcoy. Alicante.
Ya está disponible el PROGRAMA. Descargar
Normas de envío de comunicaciones:Descargar
Forumulario de envío de COMUNICACIONES
INSCRIPCIÓN Y ALOJAMIENTO